Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 21, 4 Issues, 2021
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

Most Accessed Articles

Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis

, 2021; 21(1): 30-45.

Azka Latif *, Vikas Kapoor , Noman Lateef , Muhammad J. Ahsan , Rana M. Usman , Saad U. Malik , Naqib Ahmad , Nathaniel Rosko , Joslyn Rudoni , Preethi William, Jack Khouri and Faiz Anwer


DOI: 10.2174/1871529X21666210412113017














Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review

, 2020; 20(4): 274-283.

Azka Latif*, Noman Lateef, Faryal Razzaq, Vikas Kapoor, Muhammad J. Ahsan, Muhammad Ashfaq, Ahmad Iftikhar, Faiz Anwer, Mark Holmberg and Preethi William


DOI: 10.2174/1871529X20666201130110036







Editor-in-Chief

Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog